End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.62 CNY | -1.80% | -1.30% | -25.70% |
May. 27 | Dongcheng Biochemicals' Unit Gets Nod to Trial Pancreatic Cancer Drug | MT |
May. 20 | Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Approves the Cash Dividend for the Year 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.70% | 1.58B | |
+19.08% | 43.46B | |
+24.43% | 22.61B | |
+16.48% | 15.15B | |
+22.78% | 14.83B | |
+57.41% | 13.08B | |
-0.05% | 6.79B | |
-12.44% | 6.72B | |
-8.87% | 5.73B | |
+12.71% | 5.45B |
- Stock Market
- Equities
- 002675 Stock
- News Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
- US FDA Grants Clinical Trial Approval for Dongcheng Biochemicals' Injection